Navigation Links
Hyperparathyroidism in Medical News

Nephrologists Indicate High Interest in AMAG Pharmaceuticals' Newly Approved Feraheme According to Latest BioTrends Report

...ey results from over 200 US Nephrologists. The survey was fielded in late May and focuses on trends in treatment patterns for renal anemia, secondary hyperparathyroidism and hyperphosphatemia. Nephrologists are extremely interested in AMAG's new IV iron product, Feraheme, which was approved by the FDA on June 30...

Cytochroma Announces Positive Comparative Data on CTA018 in Chronic Kidney Disease Model

...tamin D hormone replacement therapies, calcitriol and paricalcitol (Zemplar(R)), the latter currently being the most widely used therapy for secondary hyperparathyroidism (SHPT) in the United States (U.S.). These data were presented in a poster presentation entitled "The Metabolic Profile of CTA018 Confers Therapeutic a...
Hyperparathyroidism in Medical Technology

Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection

... CTA018 has potential as a treatment for secondary hyperparathyroidism in chronic kidney disease (CKD). Blood samples col... is expected to be effective in treating secondary hyperparathyroidism but safer than currently available therapies. This...ir analogues are currently used to treat secondary hyperparathyroidism in CKD and end-stage renal disease. According to t...
Hyperparathyroidism in Medical Products

Osteocalcin IRMA Test

Description:...in the liver [5]. Serum osteocalcin is elevated in disease states characterized by increased bone turnover such as renal osteodystrophy, osteoporosis, hyperparathyroidism and Pagets disease, and low in conditions associated with low bone turnover such as hypoparathyroidism and growth hormone deficiency [1]. Serum osteoc...
Company:Diagnostic Systems Laboratories, Inc.

Osteocalcin ELISA Test

Description:...in the liver [5]. Serum osteocalcin is elevated in disease states characterized by increased bone turnover such as renal osteodystrophy, osteoporosis, hyperparathyroidism and Pagets disease, and low in conditions associated with low bone turnover such as hypoparathyroidism and growth hormone deficiency [1]. Serum osteoc...
Company:Diagnostic Systems Laboratories, Inc.
Hyperparathyroidism in Medical Definition

Pathology

...pathy ) - Hypoglycemia - Hyperinsulinism - Zollinger-Ellison syndrome Parathyroid Hypoparathyroidism ( Pseudohypoparathyroidism ) - hyperparathyroidism ( Primary , Secondary , Tertiary ) Pituitary hyperfunction ( Acromegaly , Hyperprolactinaemia , Syndrome of inappropriate antidiuretic ...
Hyperparathyroidism in Medical Dictionary

Hyperparathyroidism

Hyperparathyroidism is overactivity of the parathyroid glands resulting in excess production of parathyroid hormone (PTH). The parathyroid hormone regulates calcium and phosphate levels and helps to maintain these levels.... Learn about hyperparathyroidism , a parathyroid disorder. S...

Parathyroid adenoma

...known as a parathyroid adenoma . ... Parathyroid Adenoma – Find Parathyroid Advanced Care and Parathyroid ... The most common cause of hyperparathyroidism is a parathyroid adenoma . ... Parathyroid adenoma - All Information, A parathyroid adenoma is a noncancerous (benign) tumor of the ...

Hypercalcemia

...nute news coverage of national, regional and international news enhanced with audio and video clips and photo galleries - updated 24/7... Primary hyperparathyroidism is the most common cause of hypercalcemia and is due to excess PTH. ... Hypercalcemia affects a very small percentage of the population. ... ...

Hormone levels

...se all hormone levels , particularly the androgens and ... Secondary hyperparathyroidism & Tertiary hyperparathyroidism - Parathyroid Surgery. Know the reason of high Parathyroid Hormone Level...

Calcium stones

... oxalate stones cannot be made to dissolve over time by changing to a ... The etiology of calcium stone disease is diverse. ... Primary hyperparathyroidism accounts between 5% and 10% of the calcium stone forming population. ... Part of the treatment of kidney stones involves preventing the...
Hyperparathyroidism in Biological Technology

BioTrends Releases TreatmentTrends(TM): US Nephrology, an Ongoing Syndicated Publication Providing Insight into Physician Perceptions and Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism

EXTON, Pa., Jan. 12 /PRNewswire/ -- BioTrends Research Group, Inc. released TreatmentTrends(TM): US Nephrology, a syndicated report based on online survey results from 305 Nephrologists in the US. The renal anemia market continues to show signs of stabilization. While the percent of pati...

BioTrends Releases TreatmentTrends(TM): Nephrology and Renal Dietitians, Two Syndicated Reports Providing Continuing Insight into the Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism

EXTON, Pa., Oct. 27 /PRNewswire/ -- BioTrends Research Group, Inc. released two new Nephrology TreatmentTrends(TM) publications based on survey results from 204 Nephrologists and 201 Renal Dietitians in the US. Renal Dietitians (RDs) are an integral part of the management of dialysis patients,...

BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism

EXTON, Pa., July 25 /PRNewswire/ -- BioTrends Research Group, Inc. released its 10th quarterly Nephrology TreatmentTrends(TM) publication, a syndicated report offering comprehensive insight into the management of renal anemia and bone and mineral metabolism in Chronic Kidney Disease (CKD) and ...

BioTrends Releases Two Publications - TreatmentTrends(TM): Nephrologists and TreatmentTrends(TM): Renal Dietitians - Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism

EXTON, Pa., May 6 /PRNewswire-FirstCall/ -- BioTrends Research Group, Inc. released two Nephrology TreatmentTrends(TM) Publications, both syndicated reports offering comprehensive insight into the management of renal anemia and bone and mineral metabolism in Chronic Kidney Disease (CKD) and Di...

BioTrends Releases Fourth Annual Nephrology TreatmentTrends Publication Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism

EXTON, Pa., Jan. 28 /PRNewswire/ -- BioTrends Research Group, Inc. released its Fourth Annual Nephrology TreatmentTrends Publication, a syndicated report offering comprehensive insight into the management of renal anemia and bone and mineral metabolism in Chronic Kidney Disease (CKD). The repo...

Keryx Biopharmaceuticals Reports Positive Phase 2 Study Results of Zerenex (Ferric Citrate) for the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients

...00, require dialysis. Phosphate retention and the resulting hyperphosphatemia in patients with ESRD on dialysis are usually associated with secondary hyperparathyroidism (and its related cardiovascular complications), renal osteodystrophy and soft tissue mineralization. ESRD patients usually require treatment with phos...

Cytochroma and Mitsubishi Tanabe form partnership for chronic kidney disease therapies in U.S. and Asia

...resents an important validation of our novel approach to treating secondary hyperparathyroidism in CKD patients." MTPC's President and Representative Director, Natsuki H...c in countries worldwide. About Secondary Hyperparathyroidism Secondary hyperparathyroidism ("SHPT") is a condition commonly associated with chronic kidney disease ("C...

Cytochroma Closes $45 Million Series C Financing

...ders related to altered vitamin D metabolism in chronic kidney disease ("CKD") patients, and include CTA018 and CTAP201 for the treatment of secondary hyperparathyroidism ("SHPT"), and CTAP101 for the treatment of vitamin D insufficiency. These three lead products address significant markets that are expected to grow to...

Fontus Pharmaceuticals Acquires Nephrology and Endocrinology Drug from Roche Laboratories Inc.

... has acquired ROCALTROL(R) (calcitriol) from Roche Laboratories Inc. ROCALTROL is a vitamin D analog prescribed by nephrologists for the management of hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (CRF) and by endocrinologists for the management of hyp...

Cytochroma Appoints R. Richard Wieland II As CFO

...e. Cytochroma has three lead product candidates in development for CKD patients: CTA018 and CTAP201 are being developed for the treatment of secondary hyperparathyroidism (SHPT), while CTAP101 is being developed for the treatment of Vitamin D insufficiency. About Chronic Kidney Disease According to the National Kidn...
Hyperparathyroidism in Biological Dictionary

Parathyroid glands

...e producing an excess ... Parathyroid Glands • hyperparathyroidism Treatments • hyperparathyroidism Surgery • Contact Us ... Easy to understand inf.... Your Parathyroid Glands . Hypoparathyroidism. hyperparathyroidism ... Fortunately for most people, most of the ti...
Other Tags
(Date:8/28/2014)... Blood's Thicker Than Water is based on a true ... the heart of the city. Raymond E. Blake paints this ... disrespect caused two families to collide with each other and ... Boyz and the M.O.B. Boyz clash in a rain of ... a silent terror. "Guerrilla," AKA "Real," runs his Mob family ...
(Date:8/28/2014)... August 28, 2014 Millennium Treatment Group recently ... is extremely large, and Millennium Treatment Group is working to ... that they need. , According to the National Survey ... 21 million Americans could have benefited from treatment for drug ... received help. This means that there is a large treatment ...
(Date:8/28/2014)... Lake Worth, FL (PRWEB) August 28, 2014 ... of drug use affecting users in the workplace. A ... and Drug Dependence (NCADD) states that drug abuse ... , Employees who use or are addicted to drugs ... Drug users’ activities carry over into the workplace, causing ...
(Date:8/28/2014)... 28, 2014 (HealthDay News) -- Arguments between parents may ... indicates. Parents in more than 200 families were ... At the end of each day, mothers and fathers ... with their children. On days when parents reported ... their children were also strained, according to the study ...
(Date:8/28/2014)... As the federal government plans its exit strategy from ... rethink its role in providing health care to veterans, says ... Medicine . , "To simply go on doing more of ... the Veterans Health Administration,s cost and population structure pose in ... for Health Policy & Clinical Practice, and David Auerbach, from ...
Breaking Medicine News(10 mins):Health News:Raymond E. Blake Releases Blood's Thicker Than Water, Based on a True Story 2Health News:Millennium Treatment Group Works to Close Treatment Gap 2Health News:Drug Use Causes Problems in the Workplace 2Health News:Parents' Fights May Strain Bonds With Their Kids 2Health News:A VA exit strategy 2
(Date:8/28/2014)... 2014  Privacy Advocate and Senior Staff Attorney at ... joins the lineup of biometric and mobile commerce experts ... Executive Summit in Tampa, Florida ... speakers include Steven Rahman, Director, Technology and Strategy at Samsung, ... The theme of this year,s event is Mobility at ...
(Date:8/28/2014)... 28, 2014A new method for measuring and imaging how ... and researchers better understand how drug abuse affects the ... tissue engineering, and lead to better treatment options for ... team of researchers from Stony Brook University in New ... was published today in The Optical Society,s (OSA) open-access ...
(Date:8/28/2014)... could pose a significant health risk to people with asthma ... of Allergy and Clinical Immunology . , By critically reviewing ... research has found that the presence of several types of ... well as increasing the likelihood of developing the condition. , ... University of Exeter Medical School and is the first time ...
Breaking Biology News(10 mins):Biometrics UnPlugged Welcomes the Electronic Frontier Foundation's Jennifer Lynch to the Mobility at the Crossroads of Commerce and Privacy Summit 2This is your brain's blood vessels on drugs 2This is your brain's blood vessels on drugs 3Indoor mold poses health risk to asthma sufferers 2
Other Contents